Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

NCT01611298 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome
Hodgkin Lymphoma
Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: Tetanus

Sponsor

Robert Krance

Collaborators

[object Object]
[object Object]
[object Object]